Skip to main content
Log in

Feasibility and safety of transfemoral intra-arterial chemotherapy for head and neck cancer using a 3-French catheter system: comparison with a 4-French catheter system

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

To assess the technical feasibility of transfemoral intra-arterial chemotherapy for head and neck cancer using a 3-French catheter system (3-Fr).

Materials and methods

Sixty-two patients with head and neck cancer who underwent transfemoral intra-arterial chemotherapy were included in this study. Thirty-three patients underwent treatment using a 3-Fr (group 3-Fr). Twenty-nine patients underwent treatment using a 4-French catheter system (group 4-Fr). The technical success rate, duration of the procedure with fluoroscopy, and rate of procedure-related complications were compared between group 3-Fr and group 4-Fr. In addition, in group 3-Fr, bleeding at the puncture site after 1.5 h of bed rest was evaluated.

Results

The technical success rate was 100 % in both groups. The duration of the procedure with fluoroscopy didn’t differ between group 3-Fr (mean 28.0 min) and group 4-Fr (mean 30.2 min) (p = 0.524). There was no procedure-related complication in either group. In group 3-Fr, no hemorrhagic complication was observed.

Conclusion

A 3-French catheter system can be used to perform transfemoral intra-arterial chemotherapy for head and neck cancer and is technically feasible with approximately the same duration of the procedure with fluoroscopy. Furthermore, this method may shorten the bed rest time without hemorrhagic complication, and may reduce the risk of pulmonary embolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck. 1992;14:364–71.

    Article  CAS  PubMed  Google Scholar 

  2. Robbins KT, Kumar P, Wong FS, Hartsell WF, Flick P, Palmer R, Weir AB 3rd, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell SB. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687–93.

    Article  CAS  PubMed  Google Scholar 

  3. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3rd, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Hartsell W, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Niell HB. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997;38:263–71.

    Article  CAS  PubMed  Google Scholar 

  4. Imai S, Kajihara Y, Munemori O, Kamei T, Mori T, Handa T, Akisada K, Orita Y. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol. 1995;21:94–9.

    Article  CAS  PubMed  Google Scholar 

  5. Gowda S, Bollis AM, Haikal M, Salem BI. Incidence of new focal pulmonary emboli after routine cardiac catheterization comparing the brachial to femoral approach. Cathet Cardiovasc Diagn. 1984;10:157–61.

    Article  CAS  PubMed  Google Scholar 

  6. Yasuno M, Onodera T, Kawata R, Ishida M, Saito Y, Takahashi M. Pulmonary embolism as a complication of transfemoral arteriography: incidence, symptoms, and prevention. Jpn Cric J. 1984;48:439–44.

    Article  CAS  Google Scholar 

  7. Kurokawa Y, Abiko S, Okamura T, et al. Pulmonary embolism after routine cerebral angiography: three case reports. Neurol Med Chir (Tokyo). 1995;35:305–9.

    Article  CAS  Google Scholar 

  8. Keane JF, Fellows KE, Lang P, et al. Pediatric arterial catheterization using a 3.2-French catheter. Cathet Cardiovasc Diagn. 1982;8:201–8.

    Article  CAS  PubMed  Google Scholar 

  9. Kiyosue H, Okahara M, Nagatomi H, Nakamura T, Tanoue S, Mori H. 3.3-F catheter/sheath system for use in diagnostic neuroangiography. Am J Neuroradiol. 2002;23:711–5.

    PubMed  Google Scholar 

  10. Tajima T, Yoshimitsu K, Irie H, et al. Percutaneous transfemoral hepatic arterial infusion catheter placement with the use of a downsized coaxial catheter system: technical feasibility study. J Vasc Interv Radiol. 2008;19:1196–201.

    Article  PubMed  Google Scholar 

  11. Kiyosue H, Okahara M, Nagatomi H, et al. 3.3F catheter/sheath system for use in diagnostic neuroangiography. Am. J Neuroradiol. 2002;23:711–5.

    Google Scholar 

  12. Ohuchi Y, Kaminou T, Hashimoto M, et al. Transfemoral approach using a 3.5-French catheter system for use in transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: technical assessment. Hepatogastroenterology. 2011;58:916–21.

    PubMed  Google Scholar 

  13. Pollard SD, Munks K, Wales C, et al. Position and mobilisation post-angiography study (PAMPAS): a comparison of 4.5 hours and 2.5 hours bed rest. Heart. 2003;89:447–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Kato F, Sato Y, Yuasa N, et al. Reduction of bed rest time after transfemoral noncardiac angiography from 4 hours to 2 hours: a randomized trial and a one-arm study. J Vasc Interv Radiol. 2009;20:587–92.

    Article  PubMed  Google Scholar 

  15. Steffenino G, Dellavalle A, Ribichini F, et al. Ambulation three hours after elective cardiac catheterisation through the femoral artery. Heart. 1996;75:477–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Thoré V, Berder V, Houplon P, et al. Role of manual compression time and bed rest duration on the occurrence of femoral bleeding complications after sheath retrieval following 4Fr left-sided cardiac catheterization. J Interv Cardiol. 2001;14:7–10.

    Article  PubMed  Google Scholar 

  17. Kiyosue H, Mori H, Matsumoto S, et al. Standardization of use of 4-F size catheter for selective transcatheter angiography and intervention of abdomen. Nippon Igaku Hoshasen Gakkai Zasshi. 1996;56:32–6.

    CAS  PubMed  Google Scholar 

  18. Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. 2005;23:1447–54.

    Article  CAS  PubMed  Google Scholar 

  19. Yokoyama J. Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer. Jpn J Cancer Chemother. 2002;29:169–75.

    Google Scholar 

  20. Leffers AM, Wagner A. Neurogenic complications of cerebral angiography: a retrospective study of complication rate and patient risk factors. Acta Radiol. 2000;2000(41):204–10.

    Article  Google Scholar 

  21. Wagenbach A, Saladino A, Daugherty WP, et al. Safety of early ambulation after diagnostic and therapeutic neuroendovascular procedures without use of closure device. Neurosurgery. 2010;66:493–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akira Yamamoto.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watanabe, S., Yamamoto, A., Torigoe, T. et al. Feasibility and safety of transfemoral intra-arterial chemotherapy for head and neck cancer using a 3-French catheter system: comparison with a 4-French catheter system. Jpn J Radiol 34, 148–153 (2016). https://doi.org/10.1007/s11604-015-0507-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-015-0507-1

Keywords

Navigation